Breast Imaging

FDA Finally Moves on Breast Density

New FDA national requirement for density information

After a long wait, the FDA issued a final rule that adds details on breast density reporting to the Mammography Quality Standards Act. The rule takes effect in September 2024 and should go a long way toward clarifying the issue of breast density for patients. 

Breast tissue density is a risk factor for cancer, and dense breast tissue can make it more difficult for radiologists to identify tumors on conventional x-ray mammography. This shortcoming is often not communicated to women who receive “normal” mammograms, but later find out that a cancer was missed.

Prodded by a strong patient advocacy movement, individual states have been passing laws requiring women to be notified of their density status, creating a patchwork of regulation across the U.S. 

The FDA in 2018 agreed to set a national standard by rolling breast density reporting into an update of the MQSA. But the long wait has frustrated many in the breast density advocacy movement.

There are several major components to the new rule, which: 

  • Requires breast imaging facilities to provide patients with a summary of the mammography report written in lay terms that identifies whether patients have dense or non-dense breast tissue.
  • Instructs facilities to include a section in the mammography report explaining the significance of breast density. 
  • Establishes four categories for reporting breast tissue density in the mammography report. 
  • Sets the specific language to be used for reporting density. 

The new rules provide much-needed national consistency in breast density reporting, and will replace the patchwork of state regulation that has developed over the years. Developers of breast density software may also benefit from the new federal rules, as they simplify the number of regulations that need to be tracked. 

The Takeaway

Better late than never. While the FDA should have signed off on this years ago, now that the rules are issued the breast imaging community can move ahead with integrating them into clinical practice. The new rules should also help density reporting software developers by setting a national standard rather than a patchwork of state regulation. 

Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Cardiac Imaging October 21, 2024

FFR-CT Reduces Invasive Angiography Rates October 21, 2024

Performing automated CT-derived fractional flow reserve with Shukun Technology’s software reduced referrals to invasive coronary angiography by 19% in a new study in Radiology. The findings suggest that software-based FFR-CT can serve a gatekeeper role in managing workup of patients with suspected coronary artery disease.  Cardiac CT has been a revolutionary tool for assessing people […]

Imaging IT October 18, 2024

Reduce the Mess, Reduce the Stress: Automating and Accelerating Efficiency in Complex Medical Imaging Environments October 18, 2024

Repetitive, arduous tasks are a major contributor to burnout – an increasingly prevalent issue in healthcare. While digital innovation is transformative, introducing more technology to workflows often creates additional layers of complexity, hindering efficiency, performance monitoring, and ultimately the quality of care. As a result, once-simple traditional workflows have grown cumbersome over time, filled with […]

Patient Engagement October 17, 2024

Do Imaging Costs Scare Patients? October 17, 2024

A new study in JACR reveals an uncomfortable reality about medical imaging price transparency: Patients who knew how much they would have to pay for their imaging exam were less likely to complete their study.  Price transparency has been touted as a patient-friendly tool that can get patients engaged with their care while also helping […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Imaging Wire team

You're all set!